Qiu Li

8PUBLICATIONS
0CO-AUTHORS
Exercise physiologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 31, 2023
Comments on the effects of exercise and diet on oxidative stress and telomere length in breast cancer survivors.

Peng Huang, Qiu Li

|Sep 16, 2021
Comprehensive analysis of EMT-related genes and lncRNAs in the prognosis, immunity, and drug treatment of colorectal cancer.

Yang Yang, Mingyang Feng, LiangLiang Bai

|May 02, 2020
Cost-effectiveness analysis of fruquintinib as third-line treatment for patients with metastatic colorectal cancer.

Peng-Fei Zhang, Dan Xie, Qiu Li

|Dec 20, 2019
First-line fulvestrant plus anastrozole for hormone-receptor-positive metastatic breast cancer in postmenopausal women: a cost-effectiveness analysis.

Weiting Liao, Jiaxing Huang, Qiuji Wu

|Oct 11, 2019
S-1 or gemcitabine adjuvant therapy in resected pancreatic cancer: a cost-effectiveness analysis based on the JASPAC-01 trial.

Weiting Liao, Jiaxing Huang, Guiqi Zhu

|May 08, 2019
Cost-effectiveness analysis of capecitabine plus bevacizumab versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer from Chinese societal perspective.

P-F Zhang, F Wen, J Zhou

Pageof 2

Frequent Collaborators